← Back to match
BillionToOne
Genetic testing platform for prenatal screening and liquid biopsy
Servicegrowingusage_basedus
This genetic testing platform uses a DNA molecular counter to increase cell-free DNA diagnostic resolution by over 1,000-fold, improving the ability to detect and measure disease signals in prenatal screening and liquid biopsy for cancer. It is intended for expecting parents, clinicians, and oncology patients and is offered commercially as the Unity Screen; it is not a replacement for professional medical advice.
Categories
DiagnosticsGenomicsHealth Tech

